Press release
Chronic Kidney Disease Drugs Market To Be Dominated by Keyplayers Amgen Inc., Teva Pharmaceutical Industries Ltd., Pfizer Inc., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., Sanofi S.A
Chronic-Kidney-Disease-Drugs
Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1713
Market Dynamics
The global chronic kidney disease drugs market is driven by factors such as increasing prevalence of chronic kidney disease and high presence of generic drug manufacturers in the market. According to the Centers for Disease Control & Prevention (CDC), around 15% of the adults in the U.S. were estimated to have chronic kidney disease in 2017. Individual government organizations and manufactures are indulged in research and development as well as increasing awareness about chronic kidney diseases, which is fostering growth of the chronic kidney disease drugs market.
The global chronic kidney disease drugs market was valued at US$ 12,468.2 million in 2017 and is expected to witness a robust CAGR of 3.1% over the forecast period (2018 – 2026).
Initiatives taken by government organizations and manufacturers to increase awareness of chronic kidney disease is expected to boost the market growth over the forecast period
Individual government organizations and manufacturers are working towards increasing the awareness of chronic kidney diseases. For instance, American Kidney Fund (AKF) launched comprehensive new kidney disease education portal in May 2018. The education portal called as ‘CKD Central’ will provide information and resources on chronic kidney disease (CKD).
Some major players operating in the chronic kidney disease drugs market include Amgen Inc., Teva Pharmaceutical Industries Ltd., Pfizer Inc., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., Sanofi S.A., Kissei Pharmaceutical Co. Ltd., AbbVie Inc., GlaxoSmithKline Plc, and Keryx Biopharmaceuticals Inc.
Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1713
Detailed Segmentation:
• Global Chronic Kidney Disease Drugs Market, By Drug Class:
o ACE Inhibitors
o B-Blockers
o Calcium Channel Blockers
o Diuretics
o Erythropoiesis-Stimulating Agents (ESAs)
o Others
• Global Chronic Kidney Disease Drugs Market, By Distribution Channel:
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Kidney Disease Drugs Market To Be Dominated by Keyplayers Amgen Inc., Teva Pharmaceutical Industries Ltd., Pfizer Inc., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., Sanofi S.A here
News-ID: 1446329 • Views: …
More Releases from Coherent Market Insights
U.S. Men's Underwear Market is Booming with Strong Growth Prospects | Jockey Int …
The latest report by Coherent Market Insights indicates strong growth potential for the U.S. Men's Underwear Market from 2025 to 2032, supported by rising industry demand, expanding applications, and ongoing technological advancements. The study delivers a clear overview of market size, revenue trends, and key growth factors shaping the global landscape. This research analyzes major market drivers, restraints, challenges, and emerging opportunities, while highlighting innovation trends and financial insights influencing…
Thermal Insulation Materials Market is Booming with Strong Growth Prospects | BA …
The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the Thermal Insulation Materials Market. From 2025 to 2032, this study delivers key insights, clear segmentation and actionable intelligence to help decision-makers navigate the evolving Thermal Insulation Materials Market and capitalise on upcoming opportunities.
Report Highlights
• Strategic coverage of investment hotspots, regional trend shifts and emerging…
Temperature Controlled Packaging Solutions Market 2025-2032: Growth Overview, Fa …
The latest report by Coherent Market Insights indicates strong growth potential for the Temperature Controlled Packaging Solutions Market from 2025 to 2032, supported by rising industry demand, expanding applications, and ongoing technological advancements. The study delivers a clear overview of market size, revenue trends, and key growth factors shaping the global landscape. This research analyzes major market drivers, restraints, challenges, and emerging opportunities, while highlighting innovation trends and financial insights…
Mining Floatation Chemicals Market Set for Dynamic Development with Key Players …
The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the Mining Floatation Chemicals Market. From 2025 to 2032, this study delivers key insights, clear segmentation and actionable intelligence to help decision-makers navigate the evolving Mining Floatation Chemicals Market and capitalise on upcoming opportunities.
Report Highlights
• Strategic coverage of investment hotspots, regional trend shifts and emerging…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
